Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Insulin During Cardiac Surgery
NCT02729064Phase 1Unknown
- Start
- Sep 2016
- Primary completion
- Sep 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of intranasal insulin in Post-operative cognitive dysfunction (POCD) (3 arms). Primary endpoints: Blood Glucose Concentration, Plasma Insulin Concentration and 1 more. Status: unknown.
02
Drugs
intranasal insulin
03
Conditions
Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT02729064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02729064.